This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Economopoulos, T. Articles by Dimopoulos, M. Search for Related Content PubMed PubMed Citation Articles by Economopoulos, T. Articles by Dimopoulos, M.

Multifocal Extranodal Non-Hodgkin Lymphoma: A Clinicopathologic Study of 37 Cases in Greece, a Hellenic Cooperative Oncology Group Study

^a Second Department of Internal Medicine, Athens University, University General Hospital "Attikon," Haidari, Greece; ^b Pathology Department, Evangelismos Hospital, Athens, Greece; ^c AHEPA Hospital, Aristotle University, Thessaloniki, Greece; ^d University Hospital, Alexandroupoli, Greece; ^e Medical Oncology Department, Ioannina University, Ioannina, Greece; ^f Department of Clinical Therapeutics, University of Athens, Athens, Greece

Key Words. Lymphoma • Extranodal • Multifocal

Correspondence: T. Economopoulos, University General Hospital "Attikon," 1 Rimini Str., 124 62 Haidari, Greece. Telephone: 30-210-5831255; Fax: 30-210-5326450; e-mail: sotirispapageorgiou{at}hotmail.com

The purpose of this retrospective study was to illustrate the clinicopathological features of patients presenting with multifocal extranodal non-Hodgkin lymphoma (NHL). Among 810 patients with NHL, 37 cases (4.2%) were found to have multiple extranodal involvement (two or more sites). There were 24 men and 13 women, with a median age of 63 years. The majority of these cases (n = 26) had gastric or intestinal (GI) involvement with or without other extranodal sites. Lung along with another extranodal site was relatively common in the present series. Stratification of the 37 cases according to the International Prognostic Index (IPI) showed that 89% of the patients belonged to the high-risk groups. Diffuse large-B-cell lymphoma (DLBCL) accounted for 62%, and mucosa-associated lymphoma tissue (MALT) lymphoma accounted for 27% of all cases. After induction treatment with anthracycline-based regimens, complete remission was achieved in 21 patients (57%), partial remission was achieved in six patients (16%), and seven patients (19%) had no response, while three patients (8%) were nonevaluable. In conclusion, multifocal extranodal NHL is a heterogeneous group of diseases. The majority of them arise at various sites in the GI tract. DLBCL was the most frequent histological subtype followed by MALT lymphoma. Risk group, as defined by the IPI, was predictive of survival.

This article has been cited by other articles:

				J Craig, K Walker, L Bayer, J Brunton, B Oliver, D Meiklejohn, N Kernohan, and S Tauro Multifocal primary extranodal B-cell non-Hodgkin's lymphoma involving six extranodal sites J. Clin. Pathol., January 1, 2009; 62(1): 89 - 91. [Abstract] [Full Text] [PDF]

				G. Papaxoinis, G. Fountzilas, D. Rontogianni, M. A. Dimopoulos, N. Pavlidis, C. Tsatalas, D. Pectasides, N. Xiros, and T. Economopoulos Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG) Ann. Onc., April 1, 2008; 19(4): 780 - 786. [Abstract] [Full Text] [PDF]